Marco Del Chiaro, MD

Professor, Surgery-Surgical Oncology


FacultyPhoto
Medical School
  • MD, University of Pisa, Italy (1997)
Languages
English, Italian, Swedish, French
Department
Surgery-Surgical Oncology

Professional Titles

  • Division Chief, Surgical Oncology
  • Clinical Director, Hepato-Pancreato-Biliary Program

Publications

  • Stoop TF, Theijse RT, Seelen LWF, Groot Koerkamp B, van Eijck CHJ, Wolfgang CL, van Tienhoven G, van Santvoort HC, Molenaar IQ, Wilmink JW, Del Chiaro M, Katz MHG, Hackert T, Besselink MG. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2023 Nov 30. [Epub ahead of print] PubMed PMID: 38036745
  • Fong ZV, Zwart MJW, Gorris M, Voermans RP, van Wanrooij RLJ, Wielenga T, Del Chiaro M, Arnelo U, Daams F, Busch OR, Besselink MG. Intraoperative Pancreatoscopy During Robotic Pancreatoduodenectomy and Robotic Distal Pancreatectomy for Intraductal Papillary Mucinous Neoplasm with Involvement of the Main Pancreatic Duct. Ann Surg Open. 2023 Jun;4(2):e283. PubMed PMID: 37601466
  • Stoop TF, Ghorbani P, Theijse RT, van Veldhuisen CL, DeVries JH, Groot Koerkamp B, van Santvoort HC, Molenaar IQ, Busch OR, Del Chiaro M, Besselink MG. Comment on: Pancreatectomy With Islet-Autotransplantation As Alternative for Pancreatoduodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out. Ann Surg Open. 2023 Mar;4(1):e247. PubMed PMID: 37600874
  • Stoop TF, von Gohren A, Engstrand J, Sparrelid E, Gilg S, Del Chiaro M, Ghorbani P. Risk Factors, Management, and Outcome of Gastric Venous Congestion After Total Pancreatectomy: An Underestimated Complication Requiring Standardized Identification, Grading, and Management. Ann Surg Oncol. 2023 Nov;30(12):7700-7711. PubMed PMID: 37596448
  • Stoop TF, von Gohren A, Engstrand J, Sparrelid E, Gilg S, Del Chiaro M, Ghorbani P. ASO Author Reflections: Gastric Venous Congestion After Total Pancreatectomy is an Underestimated Complication. Ann Surg Oncol. 2023 Nov;30(12):7758-7759. PubMed PMID: 37561344

Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

UCHealth Pancreas and Biliary Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Ct
3rd Floor
Aurora, CO 80045
1-855-824-7262

Hospital Affiliation
  • University of Colorado Hospital
  • Children's Hospital Colorado
  • Veterans Affairs Medical Center

Center Affiliations

Specialty Information

Specialties
  • Complex General Surgical Oncology, Board Certification
  • Surgery, Board Certification
Conditions & Treatments
  • Cancers - Biliary Cancer
  • Cancers
  • Cancers - Pancreatic Cancer
  • Digestive System - Pancreas Surgery
  • Digestive System
  • Digestive System - Biliary Surgery
  • Surgery
  • Surgery - Pancreas Transplant Surgery
  • Cancers - Cancer Prevention
  • Cancers - Cancer Surgery
  • Cancers - Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Digestive System - Gastrointestinal Surgery
Clinical Interests
Pancreas, Bile duct, Liver, Stomach, Adrenal, Sarcoma, and Cancer Surgery

Care Philosophy
Dr. Marco Del Chiaro is a surgical oncologist with 15 years of experience in the treatment of pancreatic diseases. He is internationally recognized as a leader in the surgical treatment of borderline resectable\locally advanced pancreatic cancer, as well as in the diagnosis and treatment of pancreas lesions. Dr. Del Chiaro's unique approach, combined with multimodal chemoradiotherapy, allows more surgical options for locally advanced pancreatic cancer patients. He is active in academic research, with more than 130 peer reviewed papers, and is a member of several scientific journals’ editorial boards. Dr. Del Chiaro's mission is to improve pancreatic cancer survival through both prevention and aggressive treatment of the advanced tumors and to create a multimodal personalized treatment for each patient.